Association between transfusion of blood products and acute kidney injury following cardiac surgery

Sebastian R. Rasmussen,Kristian Kandler,Rikke V. Nielsen,Peter C. Jakobsen,Marco Ranucci,Hanne B. Ravn
DOI: https://doi.org/10.1111/aas.13664
2020-07-14
Acta Anaesthesiologica Scandinavica
Abstract:BackgroundAcute kidney injury (AKI) is a serious complication following cardiac surgery associated with increased mortality. Red blood cell transfusion enhances the risk of developing AKI. However, the impact of other blood products on AKI is virtually unexplored. The aim of this study was to explore if transfusion of red blood cells, fresh frozen plasma and platelets alone or in combination was associated with postoperative AKI. MethodsPatients undergoing elective on‐pump cardiac surgery were included (n=1960) between 2012 to 2014. Transfusion data were collected intraoperatively and until the first postoperative day. AKI was classified according to the KDIGO criteria. Data were analysed using univariate and stepwise multiple logistic regression with adjustment for clinical risk factors and complementary blood products. ResultsAKI was observed in 542 patients (27.7%). In univariate analysis and following adjustment for clinical risk factors, administration of red blood cells, fresh‐frozen plasma and platelets were all independently associated with KDIGO stage 2‐3. Following additional adjustment for complementary blood products, only RBC transfusion remained significantly associated with AKI. A dose‐dependent association between volume of RBC and degree of AKI severity was observed. ConclusionTransfusion of all blood products in a dose‐dependent manner increased the risk for AKI. However, in multivariate analysis combining all blood products, only RBC transfusion remained significantly associated with AKI development.
anesthesiology
What problem does this paper attempt to address?